Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization - Concepedia

Concepedia

Publication | Open Access

Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization

DOI Full Paper Access

101

Citations

35

References

2012

Year

Timothy Y. Y. Lai, Franklin Luk, G K Y Lee, Dennis S.C. Lam

Ocular DiseaseAngiogenesisPrimary TreatmentOphthalmologyVitreous BodyLong-term OutcomeVascular BiologyNeovascularizationMedicineRadiation Oncology

References

	Year	Citations

Page 1